These syringes enable precise measurement of small liquid doses, making them ideal for medications like semaglutide and tirzepatide, which require accurate, low-volume dosing
K + efflux through these channels will hyperpolarise the pericyte
The FDA approved semaglutide in 2017 for blood sugar control in type 2 diabetes, and its weight loss effects became widely recognized in clinical populations
Individual results with any weight management treatment - prescription or otherwise - vary based on diet, activity level, medical history, baseline metabolic profile, and individual physiological response
Among the 3,532 participants in the FLOW trial, 19.2% (678 individuals) had heart failure at baseline, with 47.9% classified as having HFpEF, 18.1% as having heart failure with reduced ejection fraction (HFrEF), and 33.9% with unknown status